You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR PLASMINOGEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for plasminogen

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000468 ↗ Myocardial Infarction Triage and Intervention Project (MITI) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1988-04-01 To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy.
NCT00000468 ↗ Myocardial Infarction Triage and Intervention Project (MITI) Completed University of Washington Phase 3 1988-04-01 To determine the practicality, benefit, and safety of paramedic administration of thrombolytic therapy for acute myocardial infarction. The feasibility of paramedics correctly identifying candidates for thrombolytic therapy following myocardial infarction was assessed in Phase I. In Phase II, pre-hospital thrombolytic therapy was compared with in-hospital thrombolytic therapy.
NCT00000472 ↗ Thrombolysis in Myocardial Ischemia Trial (TIMI III) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1989-04-01 The Thrombolysis in Myocardial Ischemia Trial (TIMI III) focused on unstable angina and non-Q-wave myocardial infarction. The trial was designed to determine by coronary arteriography the incidence of coronary thrombi in these conditions and the response of these thrombi to tissue-type plasminogen activator (t-PA) in TIMI IIIA and the effects of thrombolytic therapy and of an early invasive strategy on clinical outcome in TIMI IIIB. There was also a registry with two components. A roster enumerated all patients with unstable angina or non-Q-wave myocardial infarction enrolled at cooperating hospitals. From the roster, a study population of 1,893 subjects was selected and followed prospectively for the year to determine incidence of death or myocardial infarction.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for plasminogen

Condition Name

Condition Name for plasminogen
Intervention Trials
Stroke 31
Ischemic Stroke 26
Acute Ischemic Stroke 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for plasminogen
Intervention Trials
Stroke 82
Ischemic Stroke 70
Ischemia 51
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for plasminogen

Trials by Country

Trials by Country for plasminogen
Location Trials
United States 423
China 113
Canada 41
United Kingdom 22
Egypt 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for plasminogen
Location Trials
California 31
New York 27
Pennsylvania 26
Texas 25
Maryland 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for plasminogen

Clinical Trial Phase

Clinical Trial Phase for plasminogen
Clinical Trial Phase Trials
Phase 4 70
Phase 3 82
Phase 2/Phase 3 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for plasminogen
Clinical Trial Phase Trials
Completed 153
Unknown status 51
Not yet recruiting 45
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for plasminogen

Sponsor Name

Sponsor Name for plasminogen
Sponsor Trials
National Institute of Neurological Disorders and Stroke (NINDS) 12
Genentech, Inc. 10
Assiut University 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for plasminogen
Sponsor Trials
Other 464
Industry 96
NIH 32
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.